NasdaqGM:ATAIPharmaceuticals
Is It Time To Reassess AtaiBeckley (ATAI) After Recent Biotech Sector Volatility?
If you are wondering whether AtaiBeckley is still attractively priced after its recent run, this article will walk you through what the current share price might be implying about its value.
The stock closed at US$3.57, with a 7 day return of a 5.3% decline and a 30 day return of a 4.0% decline, while the 1 year and 3 year returns of 55.2% and 88.9% put the recent weakness into a longer term context.
Recent headlines around AtaiBeckley have focused on its positioning within the...